Table 1 Patients’ clinical characteristics and laboratory index

Age,mean(SE)

54.4 ± 1.2

53.4 ± 1.6

0.197

Sex

 Male (%)

8 (13.3%)

5 (25%)

0.293

 Female (%)

52 (86.7)

15 (75%)

Histological stage

 1

11

–

–

 2

24

–

–

 3

8

–

–

 4

11

–

–

Unclear

6

–

–

ALT(U/L, median(range))

55.5 (13–893)

22.6 (9.9–109)

 < 0.0001

γGT(U/L, median(range))

210.5 (20–1218)

19.6 (5–80)

 < 0.0001

ALP(U/L, median(range))

186.1 (67–1081)

67.2 (42–128)

 < 0.0001

AST(U/L, median(range))

76 (21–730)

24 (17.1–66)

 < 0.0001

Glb(g/L, median(range))

35 (23–257)

29.3 (25.3–42)

 < 0.0001

TB(μmol/L, median(range))

27.6 (5.5–282.8)

14.05 (7.7–32.6)

 < 0.0001

DBIL(μmol/L, median(range))

11.2 (2–168.3)

2.35 (1.4–4.9)

 < 0.0001

IBIL(μmol/L, median(range))

13 (3–114.5)

11.85 (6.3–27.7)

 < 0.0001

TBA(μmol/L, median(range))

34 (0.4–268.6)

2.85 (1.7–14.8)

 < 0.0001

CHE(U/L, median(range))

5945 (374–12,580)

8495 (6729–12,532)

0.0114

IgA(g/L, median(range))

3.2 (1.4–9.6)

NA

NA

IgG(g/L, median(range))

15.9 (10.5–56.1)

NA

NA

IgM(g/L, median(range))

2.7 (0.8–8.1)

NA

NA